An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)

NCT01916967 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

239

Enrollment

INDUSTRY

Sponsor class

Conditions

Urticaria

Interventions

DRUG: Desloratadine
DRUG: Placebo

Sponsor

Organon and Co